Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KMO | O15229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15519897 | 0.94 | KMO (0.32) | GPR55LRRK2TP53MAPTKMO | |
| SCHEMBL473920 | 0.92 | MET (0.32) | GPR55LRRK2MEN1KMT2ATP53 | |
| SCHEMBL12164236 | 0.92 | MET (0.32) | GPR55LRRK2MEN1KMT2ATP53 | |
| SCHEMBL473996 | 0.90 | PTGER4 (0.33) | GPR55LRRK2TP53MAPTKMO | |
| SCHEMBL12164237 | 0.90 | PTGER4 (0.33) | GPR55LRRK2TP53MAPTKMO | |
| SCHEMBL474015 | 0.89 | KDM4E (0.33) | GPR55LRRK2MEN1KMT2ATP53 | |
| SCHEMBL12164225 | 0.89 | KDM4E (0.33) | GPR55LRRK2MEN1KMT2ATP53 | |
| SCHEMBL15520499 | 0.87 | HTR2A (0.31) | GPR55MEN1KMT2AMAPTKMO | |
| SCHEMBL15580700 | 0.87 | MET (0.32) | GPR55LRRK2MEN1KMT2ALMNA | |
| SCHEMBL12164174 | 0.84 | KMO (0.38) | MEN1KMT2ALMNAKMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411365-B1 | 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2014-03-19 | — | — | EP | claimed |